What Should Unicycive Therapeutics, Inc. Investors Know After 39.1% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
Lawsuit alleges Unicycive Therapeutics, Inc. made misleading statements to investors from December 29, 2025 to June 29, 2026; lead plaintiff motions are due November 2, 2026 LOS ANGELES, Oct. 21, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit...
Covered in this story
Call it yourself
No calls on $UNCY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Unicycive Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.